Chinnasamy et al. showed that VEGFR2 CAR T cells have an antitumor effect via effectively targeting and destroying VEGFR-2-expressing cells in the tumor vasculature while sparing non-transformed tissues (Chinnasamy et al., 2010). The gene discussed is KDR; the disease is neoplasm.